Clinical Trial Update: HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluated an HLA-DQ2-gliadin tetramer as a diagnostic test for celiac disease, with the study status listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• HLA-DQ2-gliadin tetramer

Snippet

Sponsor: Oslo University Hospital | Conditions: Celiac Disease, Gluten | Phase 2, Phase 3 | Status: COMPLETED